ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $282,135 | -24.6% | 10,500 | 0.0% | 0.04% | -20.4% |
Q2 2023 | $374,430 | +40.4% | 10,500 | 0.0% | 0.05% | +31.7% |
Q1 2023 | $266,700 | -37.4% | 10,500 | 0.0% | 0.04% | -40.6% |
Q4 2022 | $425,880 | +22.7% | 10,500 | 0.0% | 0.07% | +16.9% |
Q3 2022 | $347,000 | – | 10,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |